Skip to main content
. Author manuscript; available in PMC: 2010 Apr 22.
Published in final edited form as: Pharmacol Biochem Behav. 2008 Aug 23;91(2):261–270. doi: 10.1016/j.pbb.2008.08.018

Table 1.

Depicts serum E2, P4, DHP, and 3α,5α-THP levels of ovariectomized rats administered subcutaneous (SC) vehicle+Intra-VTA vehicle, SC vehicle+Intra-VTA 3α,5α-THP, SC E2+Intra-VTA vehicle, or SC E2+ Intra-VTA 3α,5α-THP

Experimental condition Circulating concentrations
E2
(pg/ml)		 P4
(ng/ml)		 DHP
(ng/ml)		 3α,5α-THP
(ng/ml)
SC vehicle+Intra-VTA vehicle 2.0±0.1 0.8±0.1 1.4±0.1 1.5±0.6
SC vehicle+Intra-VTA 3α,5α-THP 3.1±0.5 1.4±0.4 1.4±0.8 0.6±0.7
SC E2+Intra-VTA vehicle 29.3±4.0a 1.4±0.3 1.6±0.2 1.3±0.9
SC E2+Intra-VTA 3α,5α-THP 24.2±3.1a 0.8±0.1 1.9±1.5 1.3±1.0
a

Indicates E2 enhancement (F1,44=12.14, P<0.05).